Published in J Pharmacol Methods on May 01, 1982
Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits. Br J Pharmacol (1985) 1.35
The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats. Br J Pharmacol (1984) 0.82
Vasopressin induced myocardial depression in neurally mediated and not due to impaired coronary blood flow. Br J Pharmacol (1986) 0.75
Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol (1985) 1.49
Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem. Br J Pharmacol (1983) 1.48
Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol (1988) 1.40
Modification of vasopressin- and angiotensin II- induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits. Br J Pharmacol (1985) 1.35
PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. J Cardiovasc Pharmacol (1984) 1.19
Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol (1984) 1.11
Cardiovascular effects of apamin and BRL 34915 in rats and rabbits. Br J Pharmacol (1988) 1.06
Effect of PY 108-068, a new calcium antagonist, on general hemodynamics and regional blood flow in anesthetized cats: a comparison with nifedipine. J Cardiovasc Pharmacol (1982) 1.01
Serum lipids and their relationships with hostility and angry affect and behaviors in men. Health Psychol (2000) 0.99
Trapping and intramyocardial distribution of microspheres with different diameters in cat and rabbit hearts in vitro. Basic Res Cardiol (1982) 0.99
Assessing calcium antagonism on vascular smooth muscle: a comparison of three methods. J Pharmacol Methods (1983) 0.96
FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. Transplant Proc (2001) 0.95
Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia (1983) 0.95
Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo. J Cardiovasc Pharmacol (1983) 0.94
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392. Eur J Pharmacol (1984) 0.93
Validation studies for the use of the microsphere method in cats and young minipigs. Basic Res Cardiol (1981) 0.92
Mechanism of the vasodilator effects of the cardiotonic agent DPI 201-106. J Cardiovasc Pharmacol (1986) 0.92
Effects of hCGRP I and II on gastric blood flow and acid secretion in anesthetized rabbits. Am J Physiol (1989) 0.89
Comparison of cardiodepressant and vasodilator effects of PN 200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbits. Am J Cardiol (1987) 0.89
PY 108-068, a new, potent, and selective inhibitor of calcium-induced contraction of rabbit aortic rings. J Cardiovasc Pharmacol (1982) 0.87
Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice. Transplantation (1998) 0.86
Differential effects of antihypertensive drugs on nutritive and nonnutritive blood flow in anaesthetized rabbits. J Cardiovasc Pharmacol (1989) 0.86
Stereoselectivity at the calcium channel: different profiles of hemodynamic activity of the enantiomers of the dihydropyridine derivative PN 200-110. J Cardiovasc Pharmacol (1986) 0.86
Acceleration of blood in the aorta: a parameter useful for evaluating cardiotonic and afterload reducing substances. J Pharmacol Methods (1981) 0.85
Very small microspheres are useful for the determination of cardiac output but not organ blood flow in conscious rabbits. Experientia (1981) 0.85
PY 108-068: a calcium antagonist with an unusual pattern of cardiovascular activity. Gen Pharmacol (1985) 0.83
The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats. Br J Pharmacol (1984) 0.82
A smooth muscle cell line suitable for the study of voltage sensitive calcium channels. Biochem Biophys Res Commun (1985) 0.81
Effects of bromocriptine on the heart and the peripheral circulation of anesthetized cats. J Cardiovasc Pharmacol (1984) 0.81
Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heart. Am J Cardiol (1987) 0.81
Massive regional differences in the vascular effects of endothelin. J Hypertens Suppl (1989) 0.80
Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Transpl Immunol (2001) 0.80
The role of magnetic resonance imaging and spectroscopy in transplantation: from animal models to man. NMR Biomed (2000) 0.79
Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model. Transplantation (2000) 0.79
Effect of spirapril on left ventricular hypertrophy due to volume overload in rats. J Cardiovasc Pharmacol (1992) 0.79
Baroreflex and atrial natriuretic factor concentration correlate with myocardial infarct size and predict early death in rabbits: implications for drug studies. J Cardiovasc Pharmacol (1991) 0.79
Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals. Am J Med (1989) 0.79
Coronary ligation-reperfusion arrhythmia models in anesthetized rats and isolated perfused rat hearts concentration-effect relationships of lidocaine. J Pharmacol Methods (1986) 0.79
Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat. Blood Press (1993) 0.78
Time course of spirapril-induced structural and functional changes after myocardial infarction in rats followed with magnetic resonance imaging. J Cardiovasc Pharmacol (1993) 0.78
The renin-angiotensin system modulates the peripheral vascular effects of the calcium antagonist isradipine in anesthetized rabbits. J Cardiovasc Pharmacol (1988) 0.78
Antiarrhythmic and hemodynamic effects of tropisetron in anesthetized rabbits. J Cardiovasc Pharmacol (1993) 0.78
Effects of the enantiomers of the dihydropyridine derivative 202-791 on contractility, coronary flow and ischemia-related arrhythmias in rat heart. Eur J Pharmacol (1986) 0.78
Interaction between two calcium antagonists and two beta blockers in conscious rabbits: hemodynamic consequences of differing cardiodepressant properties. Am J Cardiol (1987) 0.78
PY 108-068, a dihydropyridine derivative, and verapamil interact differently with the ouabain effects on the heart and the peripheral circulation. Basic Res Cardiol (1985) 0.77
Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model. Transplantation (2001) 0.77
The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Transpl Immunol (2000) 0.77
Vasoconstrictor and vasodilator effects in normal and atherosclerotic conscious rabbits. Br J Pharmacol (1988) 0.77
Attenuation of endothelin-induced regional vasoconstriction by isradipine: a nonspecific antivasoconstrictor effect. J Cardiovasc Pharmacol (1990) 0.77
Proarrhythmic effects of DPI 201-106 elicited with programmed electrical stimulation: a comparison with sotalol. J Cardiovasc Pharmacol (1993) 0.77
Effects of hypothermia and rewarming on the neonatal circulation. Arch Fr Pediatr (1978) 0.76
Pharmacology of the calcium antagonist isradipine. Drugs (1990) 0.76
Cardioprotection by the calcium antagonist PN 200-110 in the absence and presence of cardiodepression. Br J Pharmacol (1985) 0.75
Vasopressin induced myocardial depression in neurally mediated and not due to impaired coronary blood flow. Br J Pharmacol (1986) 0.75
From channels to cats: an overview of isradipine pharmacology. Cor Vasa (1990) 0.75
Decreased lumen size after balloon injury despite inhibition of neointimal thickening and antivasospastic treatment. Cardiovasc Res (1994) 0.75
The Doppler method for measuring cardiac output in conscious rabbits: validation studies, uses, and limitations. J Pharmacol Methods (1990) 0.75
Assessment of right ventricle dimensions with microsonometry in anesthetized rabbits. J Pharmacol Toxicol Methods (1992) 0.75
Neointima suppression in rat carotid allografts by FTY720 combined with a small fixed cyclosporine dose is related to a diminution of the peripheral lymphocyte count. Transplant Proc (2001) 0.75
Allo- and autotransplantation of carotid artery--a new model of chronic graft vessel disease: evaluation by magnetic resonance imaging and histology. Transplantation (1997) 0.75
Mutual inhibition and synergistic effects of ergotamine and the calcium antagonist darodipine. Gen Pharmacol (1986) 0.75
Effects of isradipine on plasma renin activity in sodium-loaded and -depleted conscious rabbits. J Cardiovasc Pharmacol (1992) 0.75
Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level. J Cardiovasc Pharmacol (1993) 0.75
Baroreflex and beta-adrenoceptor function are diminished in rat cardiac hypertrophy due to volume overload. Basic Res Cardiol (1992) 0.75
Modification of the vasoconstrictor effects of noradrenaline and serotonin by the selective calcium antagonist PY 108-068 in the peripheral circulation of anesthetized cats. J Cardiovasc Pharmacol (1985) 0.75
[Rheologic findings in patients with Eales disease]. Klin Monbl Augenheilkd (1989) 0.75
Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model. Transpl Immunol (2001) 0.75
Influence of rehydration on organ blood flow after hypernatremic shock in the unrestrained young minipig. Circ Shock (1987) 0.75
Autonomic nervous system dysfunction alters drug effects: implications for testing drugs for the treatment of heart failure. J Cardiovasc Pharmacol (1992) 0.75
Hemodynamics in experimental hypernatremic dehydration with special reference to individual organ blood flow in shock and after rehydration. Pediatr Res (1983) 0.75
Effects of calcium entry blockers on calcium fluxes in a vascular smooth muscle cell line. J Hypertens Suppl (1985) 0.75
Similar increase in circulating renin after equihypotensive doses of nitroprusside, dihydralazine or isradipine in conscious rabbits. Eur J Pharmacol (1987) 0.75
Effect of hypertrophy induced by pressure overload or volume overload on reperfusion induced arrhythmias in anaesthetised rats. Cardiovasc Res (1993) 0.75
[Experiment or reform?]. Osterr Krankenpflegez (2000) 0.75
Kinetic parameters of a mixed culture oxidizing sulfide and sulfur with oxygen. Biotechnol Bioeng (1991) 0.75
Cardiovascular effects of electrical stimulation of the forebrain in the fetal lamb. Pediatr Res (1976) 0.75
Chronic adriamycin treatment and its effect on the cardiac beta-adrenergic system in the rabbit. J Cardiovasc Pharmacol (1992) 0.75
Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model. Transplant Proc (2002) 0.75
Comparative hemodynamic studies of isradipine and dihydralazine in atherosclerotic and normal rabbits. J Cardiovasc Pharmacol (1990) 0.75
Pharmacological actions of SDZ 218-135, a novel positive inotropic agent. Cardiovasc Drugs Ther (1994) 0.75